Lucky No. 13? Artiva Goes Public, Rises In First Day Of Trading

Average Biopharma Return Is -22.3% So Far In 2024

 
• By Mandy Jackson
IPO abrivation on solid background with glittery text
Artiva launched the 13th biopharma IPO in the US in 2024 • Source: Shutterstock

More from Financing

More from Business